1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Electrophysiology Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrophysiology Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Figures 5
1.2 List of Figures 11
2 Introduction 12
2.1 Electrophysiology Devices Overview 12
3 Products under Development 14
3.1 Electrophysiology Devices - Pipeline Products by Stage of Development 14
3.2 Electrophysiology Devices - Pipeline Products by Segment 15
3.3 Electrophysiology Devices - Pipeline Products by Territory 16
3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path 18
3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19
3.6 Electrophysiology Devices - Ongoing Clinical Trials 20
4 Electrophysiology Devices - Pipeline Products under Development by Companies 21
4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development 21
4.2 Electrophysiology Devices - Pipeline Products by Stage of Development 24
5 Electrophysiology Devices Companies and Product Overview 27
5.1 AblaCor Medical Corporation Company Overview 27
5.1.1 AblaCor Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 27
5.2 Acutus Medical, Inc. Company Overview 28
5.2.1 Acutus Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 28
5.3 Advanced Cardiac Therapeutics, Inc. Company Overview 30
5.3.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 30
5.4 AFfix Medical Ltd. Company Overview 31
5.4.1 AFfix Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 31
5.5 Apama Medical, Inc. Company Overview 34
5.5.1 Apama Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
5.6 AtriCure, Inc. Company Overview 35
5.6.1 AtriCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.7 Baylor College of Medicine Company Overview 41
5.7.1 Baylor College of Medicine Pipeline Products and Ongoing Clinical Trials Overview 41
5.8 Biosense Webster, Inc. Company Overview 43
5.8.1 Biosense Webster, Inc. Pipeline Products and Ongoing Clinical Trials Overview 43
5.9 BioSig Technologies, Inc. Company Overview 47
5.9.1 BioSig Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
5.10 BioTex, Inc. Company Overview 48
5.10.1 BioTex, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
5.11 Boston Scientific Corporation Company Overview 50
5.11.1 Boston Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 50
5.12 C. R. Bard, Inc. Company Overview 65
5.12.1 C. R. Bard, Inc. Pipeline Products and Ongoing Clinical Trials Overview 65
5.13 Cardima, Inc. (Inactive) Company Overview 69
5.13.1 Cardima, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 69
5.14 CardioFocus, Inc. Company Overview 72
5.14.1 CardioFocus, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
5.15 CardioNova Ltd. Company Overview 76
5.15.1 CardioNova Ltd. Pipeline Products and Ongoing Clinical Trials Overview 76
5.16 CathEffects LLC Company Overview 77
5.16.1 CathEffects LLC Pipeline Products and Ongoing Clinical Trials Overview 77
5.17 CathRx Ltd Company Overview 78
5.17.1 CathRx Ltd Pipeline Products and Ongoing Clinical Trials Overview 78
5.18 Cordis Corporation Company Overview 82
5.18.1 Cordis Corporation Pipeline Products and Ongoing Clinical Trials Overview 82
5.19 CoRepair, Inc Company Overview 84
5.19.1 CoRepair, Inc Pipeline Products and Ongoing Clinical Trials Overview 84
5.20 CyberHeart Incorporated Company Overview 85
5.20.1 CyberHeart Incorporated Pipeline Products and Ongoing Clinical Trials Overview 85
5.21 Epicardial Technologies Inc Company Overview 87
5.21.1 Epicardial Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 87
5.22 FocusStart Orthosensors Company Overview 88
5.22.1 FocusStart Orthosensors Pipeline Products and Ongoing Clinical Trials Overview 88
5.23 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 89
5.23.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products and Ongoing Clinical Trials Overview 89
5.24 Hansen Medical, Inc. Company Overview 90
5.24.1 Hansen Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 90
5.25 Imricor Medical Systems, Inc. Company Overview 97
5.25.1 Imricor Medical Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 97
5.26 Interventional Imaging, Inc. Company Overview 102
5.26.1 Interventional Imaging, Inc. Pipeline Products and Ongoing Clinical Trials Overview 102
5.27 Iowa Approach Inc. Company Overview 103
5.27.1 Iowa Approach Inc. Pipeline Products and Ongoing Clinical Trials Overview 103
5.28 Maestro Heart SA Company Overview 106
5.28.1 Maestro Heart SA Pipeline Products and Ongoing Clinical Trials Overview 106
5.29 Mayo Clinic. Company Overview 107
5.29.1 Mayo Clinic. Pipeline Products and Ongoing Clinical Trials Overview 107
5.30 MC10, Inc. Company Overview 108
5.30.1 MC10, Inc. Pipeline Products and Ongoing Clinical Trials Overview 108
5.31 Medicalgorithmics S.A. Company Overview 110
5.31.1 Medicalgorithmics S.A. Pipeline Products and Ongoing Clinical Trials Overview 110
5.32 Medispec LTD Company Overview 111
5.32.1 Medispec LTD Pipeline Products and Ongoing Clinical Trials Overview 111
5.33 Medlumics S.L. Company Overview 113
5.33.1 Medlumics S.L. Pipeline Products and Ongoing Clinical Trials Overview 113
5.34 Medtronic plc Company Overview 115
5.34.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 115
5.35 MedWaves Incorporated Company Overview 120
5.35.1 MedWaves Incorporated Pipeline Products and Ongoing Clinical Trials Overview 120
5.36 MicroPort Scientific Corporation Company Overview 122
5.36.1 MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 122
5.37 MRI Interventions, Inc Company Overview 125
5.37.1 MRI Interventions, Inc Pipeline Products and Ongoing Clinical Trials Overview 125
5.38 nContact, Inc. Company Overview 127
5.38.1 nContact, Inc. Pipeline Products and Ongoing Clinical Trials Overview 127
5.39 North Carolina State University Company Overview 131
5.39.1 North Carolina State University Pipeline Products and Ongoing Clinical Trials Overview 131
5.40 Northwestern University Company Overview 132
5.40.1 Northwestern University Pipeline Products and Ongoing Clinical Trials Overview 132
5.41 Philips Healthcare Company Overview 134
5.41.1 Philips Healthcare Pipeline Products and Ongoing Clinical Trials Overview 134
5.42 SCR, Inc. Company Overview 136
5.42.1 SCR, Inc. Pipeline Products and Ongoing Clinical Trials Overview 136
5.43 St. Jude Medical, Inc. Company Overview 137
5.43.1 St. Jude Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 137
5.44 Stereotaxis, Inc. Company Overview 144
5.44.1 Stereotaxis, Inc. Pipeline Products and Ongoing Clinical Trials Overview 144
5.45 Strategic Polymer Sciences, Inc Company Overview 147
5.45.1 Strategic Polymer Sciences, Inc Pipeline Products and Ongoing Clinical Trials Overview 147
5.46 The Cleveland Clinic Foundation Company Overview 148
5.46.1 The Cleveland Clinic Foundation Pipeline Products and Ongoing Clinical Trials Overview 148
5.47 University of Rochester Company Overview 150
5.47.1 University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 150
5.48 University of Texas Medical Branch at Galveston Company Overview 152
5.48.1 University of Texas Medical Branch at Galveston Pipeline Products and Ongoing Clinical Trials Overview 152
5.49 Vimecon GmbH Company Overview 154
5.49.1 Vimecon GmbH Pipeline Products and Ongoing Clinical Trials Overview 154
5.50 Vivonics, Inc. Company Overview 156
5.50.1 Vivonics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 156
5.51 Voyage Medical Company Overview 159
5.51.1 Voyage Medical Pipeline Products and Ongoing Clinical Trials Overview 159
6 Electrophysiology Devices- Recent Developments 161
7 Appendix 223
7.1 Methodology 223
7.2 About GlobalData 225
7.3 Contact Us 226
7.4 Disclaimer 226

1.1 List of Figures
Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development 14
Table 2: Electrophysiology Devices - Pipeline Products by Segment 15
Table 3: Electrophysiology Devices - Pipeline Products by Territory 17
Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 18
Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19
Table 6: Electrophysiology Devices - Ongoing Clinical Trials 20
Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development 21
Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development 24
Table 9: AblaCor Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 27
Table 10: AutoBlator - Product Status 27
Table 11: AutoBlator - Product Description 27
Table 12: Acutus Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 28
Table 13: AcQMap System - Product Status 29
Table 14: AcQMap System - Product Description 29
Table 15: Advanced Cardiac Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 30
Table 16: Next Generation TempaSure Ablation Catheter - Product Status 30
Table 17: Next Generation TempaSure Ablation Catheter - Product Description 30
Table 18: AFfix Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 19: Catheter Ablation Device - Product Status 31
Table 20: Catheter Ablation Device - Product Description 31
Table 21: AFfix Medical Ltd. - Ongoing Clinical Trials Overview 32
Table 22: Catheter Ablation Device - Transcutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations: a Joint Quality Initiative Pilot From Cardiac Electrophysiology and Anesthesiology 33
Table 23: Apama Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
Table 24: Apama Ablation Catheter - Product Status 34
Table 25: Apama Ablation Catheter - Product Description 34
Table 26: AtriCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 27: AtriCure MIS System - Standalone - Product Status 36
Table 28: AtriCure MIS System - Standalone - Product Description 36
Table 29: Dual Epicardial And Endocardial Device - Product Status 37
Table 30: Dual Epicardial And Endocardial Device - Product Description 37
Table 31: Next Generation RF Generator - Product Status 38
Table 32: Next Generation RF Generator - Product Description 38
Table 33: AtriCure, Inc. - Ongoing Clinical Trials Overview 39
Table 34: Dual Epicardial And Endocardial Device - Feasibility Trial of a Staged Epicardial and Endocardial Approach for Treatment of Patients with Persistent or Long Standing Persistent Atrial Fibrillation with Radiofrequency Ablation 40
Table 35: Baylor College of Medicine Pipeline Products and Ongoing Clinical Trials Overview 41
Table 36: Electrical-Anatomical Imaging Catheter - Product Status 42
Table 37: Electrical-Anatomical Imaging Catheter - Product Description 42
Table 38: Biosense Webster, Inc. Pipeline Products and Ongoing Clinical Trials Overview 43
Table 39: nMARQ Pulmonary Vein Isolation System - Product Status 44
Table 40: nMARQ Pulmonary Vein Isolation System - Product Description 44
Table 41: Biosense Webster, Inc. - Ongoing Clinical Trials Overview 45
Table 42: nMARQ Pulmonary Vein Isolation System - Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study 46
Table 43: nMARQ Pulmonary Vein Isolation System - Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler) 46
Table 44: nMARQ Pulmonary Vein Isolation System - Remarkable nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation 46
Table 45: BioSig Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 46: PURE EP System - Product Status 47
Table 47: PURE EP System - Product Description 47
Table 48: BioTex, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 49: Cooled Tip Catheter - Product Status 48
Table 50: Cooled Tip Catheter - Product Description 48
Table 51: Water-cooled Catheter - Product Status 49
Table 52: Water-cooled Catheter - Product Description 49
Table 53: Boston Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 50
Table 54: Blazer Open Irrigated Ablation Catheter - Product Status 51
Table 55: Blazer Open Irrigated Ablation Catheter - Product Description 51
Table 56: Cryo Balloon Catheter - Product Status 52
Table 57: Cryo Balloon Catheter - Product Description 52
Table 58: IntellaNav MiFi OI Catheter - Product Status 53
Table 59: IntellaNav MiFi OI Catheter - Product Description 53
Table 60: IntellaNav MiFi XP Catheter - Product Status 54
Table 61: IntellaNav MiFi XP Catheter - Product Description 54
Table 62: IntellaNav OI Catheter - Product Status 55
Table 63: IntellaNav OI Catheter - Product Description 55
Table 64: IntellaNav XP Catheter - Product Status 56
Table 65: IntellaNav XP Catheter - Product Description 56
Table 66: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Status 57
Table 67: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Description 57
Table 68: LabSystem PRO NextGen - Product Status 58
Table 69: LabSystem PRO NextGen - Product Description 58
Table 70: Lesion Assessment Device - Product Status 59
Table 71: Lesion Assessment Device - Product Description 59
Table 72: Next Generation Blazer Catheter - Product Status 60
Table 73: Next Generation Blazer Catheter - Product Description 60
Table 74: Next Generation IntellaTip Catheter - Product Status 61
Table 75: Next Generation IntellaTip Catheter - Product Description 61
Table 76: OI System - Product Status 62
Table 77: OI System - Product Description 62
Table 78: Boston Scientific Corporation - Ongoing Clinical Trials Overview 63
Table 79: Blazer Open Irrigated Ablation Catheter - Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation 64
Table 80: C. R. Bard, Inc. Pipeline Products and Ongoing Clinical Trials Overview 65
Table 81: BARD HD MESH Ablation System - Product Status 66
Table 82: BARD HD MESH Ablation System - Product Description 66
Table 83: BARD HD MESH Mapper Catheter - Product Status 67
Table 84: BARD HD MESH Mapper Catheter - Product Description 67
Table 85: ENCOMPASS - Product Status 68
Table 86: ENCOMPASS - Product Description 68
Table 87: Cardima, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 69
Table 88: CADENCE EPL - Product Status 69
Table 89: CADENCE EPL - Product Description 69
Table 90: EP Ablation System - Product Status 70
Table 91: EP Ablation System - Product Description 70
Table 92: New Energy Management Device - Product Status 71
Table 93: New Energy Management Device - Product Description 71
Table 94: CardioFocus, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
Table 95: HeartLight Endoscopic Ablation System - Product Status 73
Table 96: HeartLight Endoscopic Ablation System - Product Description 73
Table 97: CardioFocus, Inc. - Ongoing Clinical Trials Overview 74
Table 98: HeartLight Endoscopic Ablation System - Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation with the HeartLight Laser Balloon in Comparison with Irrigated Radio frequency Current Ablation 75
Table 99: HeartLight Endoscopic Ablation System - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation (Eagle AF) 75
Table 100: CardioNova Ltd. Pipeline Products and Ongoing Clinical Trials Overview 76
Table 101: Catheter To Treat Atrial Fibrillation - Product Status 76
Table 102: Catheter To Treat Atrial Fibrillation - Product Description 76
Table 103: CathEffects LLC Pipeline Products and Ongoing Clinical Trials Overview 77
Table 104: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 77
Table 105: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 77
Table 106: CathRx Ltd Pipeline Products and Ongoing Clinical Trials Overview 78
Table 107: CathRx 4mm Therapeutic Catheter - Product Status 79
Table 108: CathRx 4mm Therapeutic Catheter - Product Description 79
Table 109: CathRx 8mm Therapeutic Catheter - Product Status 80
Table 110: CathRx 8mm Therapeutic Catheter - Product Description 80
Table 111: Non-Irrigated Ablation Catheter - Product Status 81
Table 112: Non-Irrigated Ablation Catheter - Product Description 81
Table 113: Cordis Corporation Pipeline Products and Ongoing Clinical Trials Overview 82
Table 114: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 82
Table 115: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 82
Table 116: EP Lesion Assessment Device - Product Status 83
Table 117: EP Lesion Assessment Device - Product Description 83

1.2 List of Figures
Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development 14
Figure 2: Electrophysiology Devices - Pipeline Products by Segment 15
Figure 3: Electrophysiology Devices - Pipeline Products by Territory 16
Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 18
Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19
Figure 6: Electrophysiology Devices - Ongoing Clinical Trials 20

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Czech Republic Electrophysiology Devices Market Outlook to 2022

Czech Republic Electrophysiology Devices Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Electrophysiology Devices Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Electrophysiology Devices Market Outlook to 2022, provides key market data on the Czech ...

Belgium Electrophysiology Devices Market Outlook to 2022

Belgium Electrophysiology Devices Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Belgium Electrophysiology Devices Market Outlook to 2022 Summary GlobalData’s new report, Belgium Electrophysiology Devices Market Outlook to 2022, provides key market data on the Belgium Electrophysiology ...

Austria Electrophysiology Devices Market Outlook to 2022

Austria Electrophysiology Devices Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Austria Electrophysiology Devices Market Outlook to 2022 Summary GlobalData’s new report, Austria Electrophysiology Devices Market Outlook to 2022, provides key market data on the Austria Electrophysiology ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.